- •November 16, 2002
- •February 14, 2003
- •February 21
- •February 28
- •March 7
- •March 10
- •March 12
- •March 14
- •March 15
- •March 17
- •March 19
- •March 21
- •March 24
- •March 26
- •March 28
- •March 30
- •March 31
- •April 2
- •April 2
- •April 8-10
- •April 12
- •April 16
- •April 20
- •April 20
- •April 23
- •April 25
- •April 27
- •April 29
- •June 6
- •June 13
- •June 17
- •June 21
- •June 23
- •June 24
- •July 2
- •July 5
- •August 14
- •September 8
- •September 24
- •References
- •Virology
- •Discovery of the SARS Virus
- •Initial Research
- •The Breakthrough
- •Coronaviridae
- •SARS Co-V
- •Genome Sequence
- •Morphology
- •Organization
- •Detection
- •Stability and Resistance
- •Natural Host
- •Antiviral Agents and Vaccines
- •Antiviral Drugs
- •Vaccines
- •Outlook
- •References
- •Routes of Transmission
- •Factors Influencing Transmission
- •Patient Factors in Transmission
- •Asymptomatic Patients
- •Symptomatic Patients
- •Superspreaders
- •The Unsuspected Patients
- •High-Risk Activities
- •Transmission during Quarantine
- •Transmission after Recovery
- •Animal Reservoirs
- •Conclusion
- •References
- •Introduction
- •Modeling the Epidemic
- •Starting Point
- •Global Spread
- •Hong Kong
- •Vietnam
- •Toronto
- •Singapore, February 2003
- •China
- •Taiwan
- •Other Countries
- •Eradication
- •Outlook
- •References
- •Introduction
- •International Coordination
- •Advice to travelers
- •Management of SARS in the post-outbreak period
- •National Measures
- •Legislation
- •Extended Case Definition
- •Quarantine
- •Reduce travel between districts
- •Quarantine after Discharge
- •Infection Control in Healthcare Settings
- •General Measures
- •Protective Measures
- •Hand washing
- •Gloves
- •Face Masks
- •Additional protection
- •Getting undressed
- •Special Settings
- •Intensive Care Units
- •Intubating a SARS Patient
- •Anesthesia
- •Triage
- •Internet Sources
- •Additional information
- •Infection Control in Households
- •Possible Transmission from Animals
- •After the Outbreak
- •Conclusion
- •References
- •Case Definition
- •WHO Case Definition
- •Suspect case
- •Probable case
- •Exclusion criteria
- •Reclassification of cases
- •CDC Case Definition
- •Diagnostic Tests
- •Introduction
- •Laboratory tests
- •Molecular tests
- •Virus isolation
- •Antibody detection
- •Interpretation
- •Limitations
- •Biosafety considerations
- •Outlook
- •Table, Figures
- •References
- •Clinical Presentation and Diagnosis
- •Clinical Presentation
- •Hematological Manifestations
- •Atypical Presentation
- •Chest Radiographic Abnormalities
- •Chest Radiographs
- •CT Scans
- •Diagnosis
- •Clinical Course
- •Viral Load and Immunopathological Damage
- •Histopathology
- •Lung Biopsy
- •Postmortem Findings
- •Discharge and Follow-up
- •Psychosocial Issues
- •References
- •Appendix: Guidelines
- •WHO: Management of Severe Acute Respiratory Syndrome (SARS)
- •Management of Suspect and Probable SARS Cases
- •Definition of a SARS Contact
- •Management of Contacts of Probable SARS Cases
- •Management of Contacts of Suspect SARS Cases
- •SARS Treatment
- •Antibiotic therapy
- •Antiviral therapy
- •Ribavirin
- •Neuraminidase inhibitor
- •Protease inhibitor
- •Human interferons
- •Human immunoglobulins
- •Alternative medicine
- •Immunomodulatory therapy
- •Corticosteroids
- •Other immunomodulators
- •Assisted ventilation
- •Non-invasive ventilation
- •Invasive mechanical ventilation
- •Clinical outcomes
- •Outlook
- •Appendix 1
- •A standardized treatment protocol for adult SARS in Hong Kong
- •Appendix 2
- •A treatment regimen for SARS in Guangzhou, China
- •References
- •Pediatric SARS
- •Clinical Manifestation
- •Radiologic Features
- •Treatment
- •Clinical Course
- •References
Eradication 75
Eradication
As the number of new cases continues to dwindle, one of the most important questions for the future is whether SARS can be eliminated or eradicated from its new human host. Experience with many other infectious diseases, including smallpox and poliomyelitis, has demonstrated that complete eradication of an infectious disease is possible only when three precise requirements can be met (WHO Update 84):
1)An effective intervention capable of interrupting transmission – ideally, a vaccine – must be available.
2)Easy-to-use diagnostic tools are needed, with sufficient sensitivity and specificity to detect levels of infection that can lead to transmission of the disease.
3)Finally, infection of humans must be essential to the life-cycle of the causative agent – if the chain of human-to-human transmission is broken, the agent cannot survive. Existence of an animal reservoir greatly complicates eradication, but does not preclude it, provided that interventions exist to break the chain of transmission in the animal species as well.
To achieve eradication at the global level, the control intervention must be safe, simple, and affordable. Current control measures for SARS, including case detection and isolation, tracing and follow-up of contacts, and quarantine, are effective but extremely time-intensive, costly, and socially disruptive. Few, if any, countries can sustain such efforts over time (WHO Update 84).
Outlook
During the first epidemic of SARS, most countries had to deal with a small number of imported cases. When these cases were promptly detected, isolated, and managed according to strict procedures of infection control, further spread to hospital staff and family members either did not occur at all or resulted in a very small number of secondary infections (Chan-Yeung).
In countries with significant transmission of the SARS virus, the local outbreaks of Spring 2003 have been controlled; however, second out
Kamps and Hoffmann (eds.)
76 Epidemiology
breaks, such as those in Taiwan and Toronto, teach that complacency must be avoided.
Many lessons have been learned:
Only one individual is required for an outbreak. One single infected individual is sufficient to test the flexibility of modern healthcare systems to the limit;
The SARS virus is sufficiently transmissible to cause a very large epidemic if unchecked, but not so contagious as to be uncontrollable with good, basic public health measures (Dye);
The unsuspected SARS patients will be the greatest challenge in medicine if SARS cannot be eradicated
Many questions remain unsolved:
Will SARS maintain itself, with new foci appearing here and there?
Will SARS establish itself as an endemic illness, perhaps with seasonal patterns? (Holmes)
Will SARS remain confined to the areas where it is currently located, or will it spread around the world?
What would the virus do in the developing countries?
Would the transmission patterns be different if the virus was introduced into populations with a high prevalence of immunocompromised patients, i.e., people living with HIV?
References
1.Bloom BR. Lessons from SARS. Science 2003; 300: 701. http://www.sciencemag.org/feature/data/sars/pdfs/se701.pdf
2.CDC. Update: Outbreak of Severe Acute Respiratory Syndrome - Worldwide, 2003. MMWR 2003; 52:241-248.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5212a1.htm
3.CDC. Severe Acute Respiratory Syndrome - Singapore, 2003. MMWR 2003; 52: 405-11. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5218a1.htm
www.SARSreference.com
References 77
4.CDC. Severe Acute Respiratory Syndrome - Taiwan, 2003. MMWR 2003; 52: 461-66. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5220a1.htm
5.Chan-Yeung M, Yu WC. Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: case report. BMJ 2003; 326: 850-2. http://bmj.com/cgi/content/full/326/7394/850
6.Cho KO, Hoet AE, Loerch SC, et al. Evaluation of concurrent shedding of bovine coronavirus via the respiratory tract and enteric route in feedlot cattle. Am J Vet Res 2001; 62: 1436-41. http://SARSReference.com/lit.php?id=11560274
7.Drosten C, Gunther S, Preiser W, et al. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome. N Engl J Med 2003, 348:1967-76. Published online Apr 10, 2003 http://content.nejm.org/cgi/reprint/NEJMoa030747v2.pdf
8.Dye C, Gay N. Modeling the SARS epidemic. Science 2003; published online May 23. http://www.sciencemag.org/cgi/content/full/300/5627/1884
9.Field H. Possible Role of Animals. WHO Global Conference on Severe Acute Respiratory Syndrome (SARS). 17-18 June 2003. Kuala Lumpur. http://SARSReference.com/link.php?id=15
10.Government of Hong Kong Special Administrative Region, Department of Health. Outbreak of Severe Acute Respiratory Syndrome (SARS) at Amoy Gardens, Kowloon Bay, Hong Kong. http://www.info.gov.hk/info/ap/pdf/amoy_e.pdf (accessed April 30).
11.Government of Hong Kong Special Administrative Region, Department of Health. SARS Bulletin, 29 April 2003 (accessed April 30) http://www.info.gov.hk/dh/diseases/ap/eng/bulletin0429.pdf
12.Heymann D. Global response to SARS. WHO Global Conference on Severe Acute Respiratory Syndrome (SARS). 17-18 June 2003. Kuala Lumpur.
13.Holmes KV. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest 2003; 111:1605-9. http://www.jci.org/cgi/content/full/111/11/1605
Kamps and Hoffmann (eds.)
78 Epidemiology
14.Hon KL, Leung CW, Cheng WT, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003, 361:1701-3. Published online April 29, 2003. http://image.thelancet.com/extras/03let4127web.pdf
15.Hsu LY, Lee CC, Green JA, et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 2003; 9: 713-7. http://www.cdc.gov/ncidod/EID/vol9no6/03-0264.htm
16.Lee N, Hui D, Wu A, et al. A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong. N Engl J Med 2003; 348:1986-94. http://SARSReference.com/lit.php?id=12682352
17.Lipsitch M, Cohen T, Cooper B, et al. Transmission Dynamics and Control of Severe Acute Respiratory Syndrome. Science 2003; 300:1966-70. Published online May 23, 2003. http://www.sciencemag.org/cgi/content/full/300/5627/1966
18.Oxford JS, Bossuyt S, Lambkin R. A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus. Immunology 2003; 109: 326–8.
19.Parry J. Spread of SARS slows. BMJ 2003;326:1232. http://bmj.com/cgi/content/full/326/7401/1232
20.Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003, 361:1319-25. Published online Apr 8, 2003. http://image.thelancet.com/extras/03art3477web.pdf
21.Peiris JSM, Chu CM, Cheng VCC, et al. Prospective study of the clinical progression and viral load of SARS associated coronavirus pneumonia in a community outbreak. Lancet 2003. http://www.who.int/csr/sars/prospectivestudy/en/index.html
22.Poutanen SM, Low DE, Henry B, et al. Identification of Severe Acute Respiratory Syndrome in Canada. N Engl J Med 2003, 348:1995-2005. http://SARSReference.com/lit.php?id=12671061
23.Qiang G. National response to SARS: Peoples Republic of China. WHO Global Conference on Severe Acute Respiratory Syndrome (SARS). 17-18 June 2003. Kuala Lumpur.
www.SARSreference.com
References 79
24.Rosling L, Rosling M. Pneumonia causes panic in Guangdong province. BMJ 2003:326:416. http://bmj.com/cgi/content/full/326/7386/416
25.Riley S, Fraser C, Donnelly CA, et al. Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions. Science 2003; 300: 1961-6. Published online May 23, 2003. http://www.sciencemag.org/cgi/content/full/300/5627/1961
26.Spurgeon D. Toronto succumbs to SARS a second time. BMJ 2003; 326: 1162.
27.Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003 May 15;348:1977-85. http://sarsreference.com/lit.php?id=12671062
28.WHO. Severe acute respiratory syndrome (SARS): Status of the outbreak and lessons for the immediate future. Geneva, 20 May 2003. http://www.who.int/csr/media/sars_wha.pdf
29.WHO, WER 7/2003. Acute respiratory syndrome, China. Weekly Epidemiological Record 2003; 78: 41. http://www.who.int/csr/don/2003_03_12/en/
30.WHO, WER 18/2003. Viet Nam SARS-free. Weekly Epidemiological Record 2003; 78: 145. http://www.who.int/wer/pdf/2003/wer7818.pdf
31.WHO Update 35: Update on China: New numbers, May Day holiday reduced. April 21. http://www.who.int/csr/sarsarchive/2003_04_21/en/
32.WHO Update 36: Situation in Singapore and China. April 21. http://www.who.int/csr/sarsarchive/2003_04_22/en/
33.WHO Update 37: WHO extends its SARS-related travel advice to Beijing and Shanxi Province in China and to Toronto Canada. April 23. http://www.who.int/csr/sarsarchive/2003_04_23/en/
34.WHO Update 40: Situation in Shanghai, Hong Kong and Viet Nam. April 26. http://www.who.int/csr/sarsarchive/2003_04_26/en/
35.WHO Update 42: Travel advice for Toronto, situation in China. April 29. http://www.who.int/csr/sarsarchive/2003_04_29/en/
Kamps and Hoffmann (eds.)
80 Epidemiology
36.WHO Update 70. Singapore removed from list of areas with local SARS transmission. http://www.who.int/entity/csr/don/2003_05_30a/en
37.WHO Update 84. Can SARS be eradicated or eliminated? http://www.who.int/entity/csr/don/2003_06_19/en
38.WHO Update 87. World Health Organization changes last remaining travel recommendation for Beijing, China. http://www.who.int/entity/csr/don/2003_06_24/en
39.WHO Update 92. Chronology of travel recommendations, areas with local transmission. http://www.who.int/entity/csr/don/2003_07_01/en
40.WHO Update 93. Toronto removed from list of areas with recent local transmission. http://www.who.int/entity/csr/don/2003_07_02/en
41.WHO Update 96. Taiwan, China: SARS transmission interrupted in last outbreak area. http://www.who.int/csr/don/2003_07_05/en/
42.WHO. Viet Nam removed from list of affected countries, more than 5000 probable cases worldwide. April 28. http://www.who.int/csr/sarsarchive/2003_04_28/en/
43.Yeoh E-k. National response to SARS: Peoples Republic of China. WHO Global Conference on Severe Acute Respiratory Syndrome (SARS). 17-18 June 2003. Kuala Lumpur. http://SARSReference.com/link.php?id=16
www.SARSreference.com